Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mouse gut metagenome

ABSTRACT: Intestinal microbiome analysis of mice infected with Strongyloides venezuelensis

PROVIDER: PRJDB7625 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DRR198853_1.fastq.gz	Fastqsanger.gz
	DRR198853_2.fastq.gz	Fastqsanger.gz
	DRR199091_1.fastq.gz	Fastqsanger.gz
	DRR199091_2.fastq.gz	Fastqsanger.gz
	DRR199092_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 98

Similar Datasets

Composition analysis of Strongyloides venezuelensis Larvae proteome

Project description:This project is a compositional analysis of L3 larvae stage of Strongyloides Venezuelensis.

2020-01-09 | PXD013703 | Pride

mouse gut metagenome

Project description:Intestinal microbiome of CD-1 mice

| PRJNA1045335 | ENA

Strongyloides venezuelensis

Project description:Transcriptome analysis of Strongyloides venezuelensis

| PRJDB1792 | ENA

Strongyloides venezuelensis

Project description:Strongyloides venezuelensis transcriptome

| PRJDB3457 | ENA

Strongyloides venezuelensis

Project description:Strongyloides venezuelensis overview

| PRJNA83715 | ENA

mouse gut metagenome

Project description:Effect of Bifidobacterium on the intestinal microbiota in rotavirus infected mice

| PRJDB5499 | ENA

Strongyloides venezuelensis strain:Miyazaki breed

Project description:Strongyloides venezuelensis transcriptome project

| PRJNA51815 | ENA

mouse gut metagenome

Project description:Gut microbiome analysis of renal failure mice

| PRJDB2888 | ENA

mouse gut metagenome

Project description:16S amplicon sequence analysis of gut microbiome in intestinal epithelial cell-specific alpha-mannosidase II deficient mice

| PRJDB6474 | ENA

Directed Remodeling of the Mouse Gut Microbiome Inhibits the Development of Atherosclerosis [mouse tissue]

Project description:The gut microbiome is a malleable microbial community that can remodel in response to various factors, including diet, and contribute to the development of several chronic diseases, including atherosclerosis. We devised an in vitro screening protocol of the mouse gut microbiome to discover molecules that can selectively modify bacterial growth. This approach was used to identify cyclic D,L-α-peptides that remodeled the Western diet (WD) gut microbiome toward the low-fat-diet microbiome state. Daily oral administration of the peptides in WD-fed LDLr-/- mice reduced plasma total cholesterol levels and atherosclerotic plaques. Depletion of the microbiome with antibiotics abrogated these effects. Peptide treatment reprogrammed the microbiome transcriptome, suppressed the production of pro-inflammatory cytokines (including interleukin-6, tumor necrosis factor-α and interleukin-1β), rebalanced levels of short-chain fatty acids and bile acids, improved gut barrier integrity and increased intestinal T regulatory cells. Directed chemical manipulation provides an additional tool for deciphering the chemical biology of the gut microbiome and might advance microbiome-targeted therapeutics.

2019-12-31 | GSE104914 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data